Literature DB >> 30152716

Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis.

Amit Khurana1, Sravani Tekula1, Chandraiah Godugu1.   

Abstract

AIM: The present study was designed to probe the antidiabetic effects of nanoceria (NC) in Type 1 diabetes (T1DM). MATERIALS &
METHODS: NC was characterized using scanning electron microscopy, Fourier transform IR, powder x-ray diffraction and zeta sizer. Multiple low doses of streptozotocin (40 mg/kg, intraperitoneally, five consecutive days) induced Type 1 diabetic Swiss mice were treated with NC at two doses (0.2 and 2 mg/kg, ip.).
RESULTS: NC treatment significantly reduced glucose levels and diabetogenesis to 50% (4/8 animals) at 0.2 mg/kg and 37.5% (3/8 animals) at 2.0 mg/kg doses. Cytokines (IL-6 and TNF-α; p < 0.048 at 2 mg/kg) and p65-NF-κB expression were diminished by NC treatment whereas the Nrf2 expression was enhanced by NC intervention indicating the role of modulation of NF-κB/Nrf2 pathway. NC exhibited promising superoxide dismutase 1 mimetic and anti-apoptotic activity.
CONCLUSION: Considered together, our data establishes the antidiabetic potential of NC which may become a novel strategy to combat T1DM in the near future.

Entities:  

Keywords:  NF-κB; Nrf2; SOD1; Type 1 diabetes mellitus; apoptosis; caspase-3; inflammation; nanoceria; oxidative stress; pancreas

Mesh:

Substances:

Year:  2018        PMID: 30152716     DOI: 10.2217/nnm-2018-0085

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  8 in total

Review 1.  Efficacy of Green Cerium Oxide Nanoparticles for Potential Therapeutic Applications: Circumstantial Insight on Mechanistic Aspects.

Authors:  Maarij Khan; Zia-Ur-Rehman Mashwani; Muhammad Ikram; Naveed I Raja; Azza H Mohamed; Guogang Ren; Ahmad A Omar
Journal:  Nanomaterials (Basel)       Date:  2022-06-20       Impact factor: 5.719

2.  Antiapoptotic and antioxidative effects of cerium oxide nanoparticles on the testicular tissues of streptozotocin-induced diabetic rats: An experimental study.

Authors:  Torab Solgi; Iraj Amiri; Sara Soleimani Asl; Massoud Saidijam; Banafsheh Mirzaei Seresht; Tayebe Artimani
Journal:  Int J Reprod Biomed       Date:  2021-08-16

Review 3.  Synthesis and biomedical applications of nanoceria, a redox active nanoparticle.

Authors:  Neelam Thakur; Prasenjit Manna; Joydeep Das
Journal:  J Nanobiotechnology       Date:  2019-07-10       Impact factor: 10.435

Review 4.  Cerium Oxide Nanoparticles (Nanoceria): Hopes in Soft Tissue Engineering.

Authors:  Hossein Sadidi; Sara Hooshmand; Ali Ahmadabadi; Seyed Javad Hosseini; Francesco Baino; Morvarid Vatanpour; Saeid Kargozar
Journal:  Molecules       Date:  2020-10-06       Impact factor: 4.411

Review 5.  On Placental Toxicology Studies and Cerium Dioxide Nanoparticles.

Authors:  Gaëlle Deval; Sonja Boland; Thierry Fournier; Ioana Ferecatu
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

6.  Preparation, Characterization and Multiple Biological Properties of Peptide-Modified Cerium Oxide Nanoparticles.

Authors:  Mengjun Wang; Hongliang He; Di Liu; Ming Ma; Yu Zhang
Journal:  Biomolecules       Date:  2022-09-10

7.  Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats.

Authors:  Bernat Córdoba-Jover; Altamira Arce-Cerezo; Jordi Ribera; Montse Pauta; Denise Oró; Gregori Casals; Guillermo Fernández-Varo; Eudald Casals; Victor Puntes; Wladimiro Jiménez; Manuel Morales-Ruiz
Journal:  J Nanobiotechnology       Date:  2019-10-31       Impact factor: 10.435

8.  Nanoceria as a possible agent for the management of COVID-19.

Authors:  Prince Allawadhi; Amit Khurana; Sachin Allwadhi; Kamaldeep Joshi; Gopinath Packirisamy; Kala Kumar Bharani
Journal:  Nano Today       Date:  2020-09-15       Impact factor: 18.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.